About Waldencast plc
http://www.waldencast.comWaldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals.
CEO
Michel Brousset
Compensation Summary
(Year )
Price Target
Institutional Ownership
ZENO EQUITY PARTNERS LLP
Shares:4.89M
Value:$190.82K
LMR PARTNERS LLP
Shares:1.24M
Value:$48.34K
MILESTONES ADMINISTRADORA DE RECURSOS LTDA.
Shares:440.42K
Value:$17.18K
Summary
Showing Top 3 of 25
About Waldencast plc
http://www.waldencast.comWaldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $132.27M ▼ | $93.81M ▼ | $-169.44M ▼ | -128.1% ▼ | $-1.51 ▼ | $-151.48M ▼ |
| Q4-2024 | $142.29M ▲ | $128.64M ▲ | $-32.37M ▼ | -22.75% ▼ | $-0.29 ▼ | $-1.12M ▼ |
| Q2-2024 | $131.58M ▲ | $121.68M ▲ | $-10.07M ▲ | -7.66% ▲ | $-0.09 ▲ | $1.73M ▲ |
| Q4-2023 | $108.8M ▼ | $120.1M ▲ | $-78.21M ▼ | -71.88% ▼ | $-0.64 ▼ | $-18.48M ▲ |
| Q2-2023 | $109.34M | $100.62M | $-11.77M | -10.77% | $-0.11 | $-23.73M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $10.48M ▼ | $797.75M ▼ | $248.78M ▲ | $499.14M ▼ |
| Q4-2024 | $14.8M ▼ | $975.86M ▼ | $245.92M ▼ | $662.32M ▲ |
| Q2-2024 | $19.69M ▼ | $1.01B ▼ | $253.21M ▼ | $618.61M ▼ |
| Q4-2023 | $22.58M ▲ | $1.04B ▼ | $273.44M ▼ | $624.63M ▲ |
| Q2-2023 | $18.9M | $1.09B | $318.25M | $615.28M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-169.44M ▼ | $-11.53M ▼ | $-3.33M ▼ | $10.07M ▲ | $-5.83M ▼ | $-14.1M ▼ |
| Q4-2024 | $-32.37M ▼ | $2.56M ▲ | $-1.52M ▼ | $-5.73M ▼ | $-4.88M ▼ | $1.14M ▲ |
| Q2-2024 | $-10.07M ▲ | $-11.38M ▲ | $-1.4M ▼ | $11.31M ▼ | $-1.39M ▲ | $-12.67M ▲ |
| Q4-2023 | $-60.57M ▼ | $-13.41M ▲ | $-610K ▲ | $15.05M ▼ | $-21.67M ▼ | $-13.86M ▲ |
| Q2-2023 | $-29.41M | $-16.36M | $-1.38M | $29.28M | $21.67M | $-17.51M |
Revenue by Products
| Product | Q4-2022 |
|---|---|
 Product | $90.00M ▲ |
 Royalty | $0 ▲ |
Revenue by Geography
| Region | Q4-2022 |
|---|---|
 CHINA | $20.00M ▲ |
 UNITED STATES | $50.00M ▲ |
CEO
Michel Brousset
Compensation Summary
(Year )
Price Target
Institutional Ownership
ZENO EQUITY PARTNERS LLP
Shares:4.89M
Value:$190.82K
LMR PARTNERS LLP
Shares:1.24M
Value:$48.34K
MILESTONES ADMINISTRADORA DE RECURSOS LTDA.
Shares:440.42K
Value:$17.18K
Summary
Showing Top 3 of 25